204 Mazdutide, a dual GLP-1/glucagon RA, and retatrutide, a triple GLP-1/GIP/glucagon RA, also have both shown significant weight loss effects in Phase 2 trials
So, why would you want to give your body a molecule that it doesnt make
Hydrocortisone [hsdb] 288
October 2, 2024: The FDA updated the status for tirzepatide injections on the shortage list from Currently in Shortage to Resolved. This change meant that Tirzepatide injections, marketed under the brand names Zepbound and Mounjaro by Eli Lilly, could no longer be compounded by 503A Compounding Pharmacies or 503B Outsourcing Facilities
Following heme internalization, heme oxygenase-1 (HMOX-1) degrades heme to produce bilirubin, carbon monoxide, and ferrous ions, which inhibit the interactions of iron-binding proteins with iron response elements in FPN mRNA, thereby upregulating FPN expression and promoting tumor growth (81)
Massive and rapid infusion through an intravenous line might be hard on the kidneys, or it could even trigger an unusual skin reaction